デフォルト表紙
市場調査レポート
商品コード
1762264

細胞治療技術市場、規模、シェア、動向、産業分析レポート:治療タイプ別、技術別、用途別、地域別、2025年~2034年の市場予測

Cell Therapy Technologies Market Size, Share, Trends, Industry Analysis Report: By Therapy Type, Technology, Application, and Region - Market Forecast, 2025-2034


出版日
ページ情報
英文 120 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.09円
細胞治療技術市場、規模、シェア、動向、産業分析レポート:治療タイプ別、技術別、用途別、地域別、2025年~2034年の市場予測
出版日: 2025年05月01日
発行: Polaris Market Research
ページ情報: 英文 120 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の細胞治療技術市場規模は2034年までに444億3,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

細胞治療技術は、様々な疾患の治療のための細胞ベースの治療を開発、製造、提供するために使用されるツール、機器、システムを包含します。これらの技術は、治療用細胞の生存性と機能性を確保するために、細胞の分離、拡大、改変、保存などの主要プロセスをサポートします。これらの技術は、再生医療、免疫療法、幹細胞研究に広く利用され、がん、神経疾患、心血管疾患、自己免疫疾患などの治療に役立っています。遺伝子編集、バイオプロセッシング、凍結保存などの治療技術の進歩により、細胞治療技術は細胞ベースの治療の安全性、拡張性、有効性を高める上で極めて重要な役割を果たし続けています。

細胞治療技術市場の拡大は、再生医療における研究の増加と革新的な治療オプションに対する需要の高まりによってもたらされます。この市場は、自動化、バイオリアクター技術、ゲノム編集ツールの進歩によって製造プロセスが合理化され、治療成績が向上しています。バイオテクノロジー企業やヘルスケア機関からの投資の増加とともに、細胞ベースの治療に対する規制上の支援が市場成長をさらに促進しています。さらに、研究機関と業界各社との共同研究が技術開発を加速させ、細胞治療ソリューションへの幅広いアクセスを確保しています。個別化医療が勢いを増すにつれて、効率的で拡張性の高い細胞治療技術への需要が高まり、現代ヘルスケアの未来が形作られると予想されます。

細胞治療技術市場レポートハイライト

治療法の種類別では、免疫拒絶反応のリスクが低いこと、個別化医療での採用が増加していることから、自己細胞療法分野が細胞療法技術市場で大きなシェアを占めています。これらの治療法は再生医療やがん治療に広く使用されており、市場での優位性に寄与しています。

技術別では、ウイルスベクター技術分野が市場をリードしています。ウイルスベクターは、正確な遺伝子改変を可能にすることで、遺伝子治療や細胞治療の応用において重要な役割を果たしているからです。CAR-T細胞療法のような先進的な治療法の開発におけるその確立された使用は、その広範な採用と高い市場需要を確実なものにしています。

用途別では、がんの有病率が上昇し、細胞ベースの免疫療法の採用が増加していることから、2024年にはがん領域が支配的なセグメントとなっています。がん領域における細胞治療製品の承認数が増加していることが、同市場における地位を強化しています。

地域別では、北米が細胞治療技術市場の収益で最大のシェアを占めています。これは、同地域の高度なヘルスケアインフラ、研究開発への多額の投資、支持的な規制環境に起因しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の細胞治療技術市場の洞察

  • 市場スナップショット
  • 細胞治療技術市場力学
    • 促進要因と機会
      • 政府の資金と支援の増強
      • 遺伝子編集技術の進歩
    • 抑制要因と課題
      • 複雑な規制承認プロセス
  • PESTEL分析
  • 細胞治療技術市場のアプリケーション動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界の細胞治療技術市場:治療タイプ別

  • 主な調査結果
  • イントロダクション
  • 同種療法
  • 自家移植療法

第6章 世界の細胞治療技術市場:技術別

  • 主な調査結果
  • イントロダクション
  • 体細胞技術
  • 細胞不死化技術
  • ウイルスベクター技術
  • ゲノム編集技術
  • 細胞可塑性技術

第7章 世界の細胞治療技術市場:用途別

  • 主な調査結果
  • イントロダクション
  • 筋骨格
  • 心血管系
  • 胃腸
  • 神経学的
  • 腫瘍学
  • 皮膚科
  • 創傷と負傷
  • 眼科
  • その他

第8章 世界の細胞治療技術市場:地域別

  • 主な調査結果
  • イントロダクション
    • 細胞治療技術市場分析:地域別、2020~2034年
  • 北米
    • 北米:治療タイプ別、2020~2034年
    • 北米:技術別、2020~2034年
    • 北米:用途別、2020~2034年
    • 米国
    • カナダ
  • 欧州
    • 欧州:治療タイプ別、2020~2034年
    • 欧州:技術別、2020~2034年
    • 欧州:用途別、2020~2034年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋地域
    • アジア太平洋地域:治療タイプ別、2020~2034年
    • アジア太平洋地域:技術別、2020~2034年
    • アジア太平洋地域:用途別、2020~2034年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ
    • 中東・アフリカ:治療タイプ別、2020~2034年
    • 中東・アフリカ:技術別、2020~2034年
    • 中東・アフリカ:用途別、2020~2034年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ
  • ラテンアメリカ
    • ラテンアメリカ:治療タイプ別、2020-2034年
    • ラテンアメリカ:技術別、2020~2034年
    • ラテンアメリカ:用途別、2020~2034年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Agilent Technologies Inc.
  • Avantor, Inc.
  • Becton, Dickinson and Company(BD)
  • Bio-Techne Corporation
  • Corning Incorporated
  • Danaher Corporation
  • Fresenius SE & Co. KGaA
  • Lonza Group AG
  • Merck KGaA
  • Sartorius AG
  • Terumo Corporation
  • Thermo Fisher Scientific Inc
図表

List of Tables:

  • Table 1 Global Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 2 Global Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 3 Global Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 4 North America: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 5 North America: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 6 North America: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 7 U.S.: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 8 U.S.: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 9 U.S.: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 10 Canada: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 11 Canada: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 12 Canada: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 13 Europe: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 14 Europe: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 15 Europe: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 16 UK: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 17 UK: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 18 UK: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 19 France: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 20 France: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 21 France: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 22 Germany: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 23 Germany: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 24 Germany: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 25 Italy: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 26 Italy: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 27 Italy: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 28 Spain: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 29 Spain: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 30 Spain: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 34 Russia: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 35 Russia: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 36 Russia: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 43 China: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 44 China: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 45 China: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 46 India: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 47 India: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 48 India: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 52 Japan: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 53 Japan: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 54 Japan: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 58 South Korea: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 59 South Korea: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 60 South Korea: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 61 Australia: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 62 Australia: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 63 Australia: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 73 UAE: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 74 UAE: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 75 UAE: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 76 Israel: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 77 Israel: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 78 Israel: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 79 South Africa: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 80 South Africa: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 81 South Africa: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 85 Latin America: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 86 Latin America: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 87 Latin America: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 88 Mexico: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 89 Mexico: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 90 Mexico: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 91 Brazil: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 92 Brazil: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 93 Brazil: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 94 Argentina: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 95 Argentina: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 96 Argentina: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Cell Therapy Technologies Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Therapy Type
  • Figure 7. Global Cell Therapy Technologies Market, by Therapy Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Technology
  • Figure 9. Global Cell Therapy Technologies Market, by Technology, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Application
  • Figure 11. Global Cell Therapy Technologies Market, by Application, 2024 & 2034 (USD Billion)
目次
Product Code: PM2626

The global cell therapy technologies market size is expected to reach USD 44.43 billion by 2034, according to a new study by Polaris Market Research. The report "Cell Therapy Technologies Market Size, Share, Trends, Industry Analysis Report: By Therapy Type (Allogeneic Therapies and Autologous Therapies), Technology, Application, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Cell therapy technologies encompass the tools, equipment, and systems used to develop, manufacture, and deliver cell-based therapies for treating various diseases. These technologies support key processes such as cell isolation, expansion, modification, and preservation to ensure the viability and functionality of therapeutic cells. They are widely utilized in regenerative medicine, immunotherapy, and stem cell research, aiding in the treatment of conditions such as cancer, neurological disorders, cardiovascular diseases, and autoimmune disorders. With advancements in gene editing, bioprocessing, and cryopreservation, cell therapy technologies continue to play a pivotal role in enhancing the safety, scalability, and efficacy of cell-based treatments.

The cell therapy technologies market expansion is driven by increasing research in regenerative medicine and the rising demand for innovative treatment options. The market benefits from advancements in automation, bioreactor technology, and genome editing tools that streamline manufacturing processes and improve therapeutic outcomes. Regulatory support for cell-based therapies, along with growing investments from biotechnology firms and healthcare institutions, is further fueling market growth. Additionally, collaborations between research organizations and industry players are accelerating technological developments, ensuring wider accessibility of cell therapy solutions. As personalized medicine gains momentum, the demand for efficient and scalable cell therapy technologies is expected to rise, shaping the future of modern healthcare.

Cell Therapy Technologies Market Report Highlights

By therapy type, the autologous therapies segment holds a larger cell therapy technologies market share due to their lower risk of immune rejection and increasing adoption in personalized medicine. These therapies are widely used in regenerative medicine and oncology treatments, contributing to their dominance in the market.

By technology, the viral vector technology segment leads the market, as it plays a crucial role in gene and cell therapy applications by enabling precise genetic modifications. Its established use in developing advanced therapies, such as CAR-T cell therapy, ensures its widespread adoption and high market demand.

By application, oncology was the dominant segment in 2024 due to the rising prevalence of cancer and the growing adoption of cell-based immunotherapies. The increasing number of regulatory approvals for cell therapy products in oncology has strengthened its position in the market.

By region, North America holds the largest share of the cell therapy technologies market revenue. This is attributed to the region's advanced healthcare infrastructure, substantial investments in research and development, and a supportive regulatory environment.

The cell therapy technologies market features several prominent companies actively contributing to its advancement. A few key players include Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Lonza Group AG; Sartorius AG; Agilent Technologies Inc.; Avantor, Inc.; Bio-Techne Corporation; Fresenius SE & Co. KGaA; Becton, Dickinson and Company (BD); Corning Incorporated; and Terumo Corporation.

Polaris Market Research has segmented the Cell Therapy Technologies market report on the basis of therapy type, technology, application, and region:

By Therapy Type Outlook (Revenue - USD Billion, 2020-2034)

Allogeneic Therapies

Autologous Therapies

By Technology Outlook (Revenue - USD Billion, 2020-2034)

Somatic Cell Technology

Cell Immortalization Technology

Viral Vector Technology

Genome Editing Technology

Cell Plasticity Technology

By Application Outlook (Revenue - USD Billion, 2020-2034)

Musculoskeletal

Cardiovascular

Gastrointestinal

Neurological

Oncology

Dermatology

Wound and Injuries

Ocular

Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

US

Canada

Mexico

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Cell Therapy Technologies Market Insights

  • 4.1. Cell Therapy Technologies Market - Market Snapshot
  • 4.2. Cell Therapy Technologies Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Government Funding and Support
      • 4.2.1.2. Advancements in Gene Editing Technologies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Complex regulatory approval process
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Cell Therapy Technologies Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Cell Therapy Technologies Market, by Therapy Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • 5.3. Allogeneic Therapies
    • 5.3.1. Global Cell Therapy Technologies Market, by Allogeneic Therapies, by Region, 2020-2034 (USD Billion)
  • 5.4. Autologous Therapies
    • 5.4.1. Global Cell Therapy Technologies Market, by Autologous Therapies, by Region, 2020-2034 (USD Billion)

6. Global Cell Therapy Technologies Market, by Technology

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • 6.3. Somatic Cell Technology
    • 6.3.1. Global Cell Therapy Technologies Market, by Somatic Cell Technology, by Region, 2020-2034 (USD Billion)
  • 6.4. Cell Immortalization Technology
    • 6.4.1. Global Cell Therapy Technologies Market, by Cell Immortalization Technology, by Region, 2020-2034 (USD Billion)
  • 6.5. Viral Vector Technology
    • 6.5.1. Global Cell Therapy Technologies Market, by Viral Vector Technology, by Region, 2020-2034 (USD Billion)
  • 6.6. Genome Editing Technology
    • 6.6.1. Global Cell Therapy Technologies Market, by Genome Editing Technology, by Region, 2020-2034 (USD Billion)
  • 6.7. Cell Plasticity Technology
    • 6.7.1. Global Cell Therapy Technologies Market, by Cell Plasticity Technology, by Region, 2020-2034 (USD Billion)

7. Global Cell Therapy Technologies Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 7.3. Musculoskeletal
    • 7.3.1. Global Cell Therapy Technologies Market, by Musculoskeletal, by Region, 2020-2034 (USD Billion)
  • 7.4. Cardiovascular
    • 7.4.1. Global Cell Therapy Technologies Market, by Cardiovascular, by Region, 2020-2034 (USD Billion)
  • 7.5. Gastrointestinal
    • 7.5.1. Global Cell Therapy Technologies Market, by Gastrointestinal, by Region, 2020-2034 (USD Billion)
  • 7.6. Neurological
    • 7.6.1. Global Cell Therapy Technologies Market, by Neurological, by Region, 2020-2034 (USD Billion)
  • 7.7. Oncology
    • 7.7.1. Global Cell Therapy Technologies Market, by Oncology, by Region, 2020-2034 (USD Billion)
  • 7.8. Dermatology
    • 7.8.1. Global Cell Therapy Technologies Market, by Dermatology, by Region, 2020-2034 (USD Billion)
  • 7.9. Wound and Injuries
    • 7.9.1. Global Cell Therapy Technologies Market, by Wound and Injuries, by Region, 2020-2034 (USD Billion)
  • 7.10. Ocular
    • 7.10.1. Global Cell Therapy Technologies Market, by Ocular, by Region, 2020-2034 (USD Billion)
  • 7.11. Others
    • 7.11.1. Global Cell Therapy Technologies Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Cell Therapy Technologies Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Cell Therapy Technologies Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Cell Therapy Technologies Market - North America
    • 8.3.1. North America: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.3.3. North America: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
    • 8.3.4. Cell Therapy Technologies Market - U.S.
      • 8.3.4.1. U.S.: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
    • 8.3.5. Cell Therapy Technologies Market - Canada
      • 8.3.5.1. Canada: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.4. Cell Therapy Technologies Market - Europe
    • 8.4.1. Europe: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
    • 8.4.4. Cell Therapy Technologies Market - UK
      • 8.4.4.1. UK: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
    • 8.4.5. Cell Therapy Technologies Market - France
      • 8.4.5.1. France: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
    • 8.4.6. Cell Therapy Technologies Market - Germany
      • 8.4.6.1. Germany: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
    • 8.4.7. Cell Therapy Technologies Market - Italy
      • 8.4.7.1. Italy: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
    • 8.4.8. Cell Therapy Technologies Market - Spain
      • 8.4.8.1. Spain: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
    • 8.4.9. Cell Therapy Technologies Market - Netherlands
      • 8.4.9.1. Netherlands: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
    • 8.4.10. Cell Therapy Technologies Market - Russia
      • 8.4.10.1. Russia: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
    • 8.4.11. Cell Therapy Technologies Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.5. Cell Therapy Technologies Market - Asia Pacific
    • 8.5.1. Asia Pacific: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
    • 8.5.4. Cell Therapy Technologies Market - China
      • 8.5.4.1. China: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
    • 8.5.5. Cell Therapy Technologies Market - India
      • 8.5.5.1. India: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
    • 8.5.6. Cell Therapy Technologies Market - Malaysia
      • 8.5.6.1. Malaysia: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
    • 8.5.7. Cell Therapy Technologies Market - Japan
      • 8.5.7.1. Japan: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
    • 8.5.8. Cell Therapy Technologies Market - Indonesia
      • 8.5.8.1. Indonesia: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
    • 8.5.9. Cell Therapy Technologies Market - South Korea
      • 8.5.9.1. South Korea: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
    • 8.5.10. Cell Therapy Technologies Market - Australia
      • 8.5.10.1. Australia: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
    • 8.5.11. Cell Therapy Technologies Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.6. Cell Therapy Technologies Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
    • 8.6.4. Cell Therapy Technologies Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
    • 8.6.5. Cell Therapy Technologies Market - UAE
      • 8.6.5.1. UAE: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
    • 8.6.6. Cell Therapy Technologies Market - Israel
      • 8.6.6.1. Israel: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
    • 8.6.7. Cell Therapy Technologies Market - South Africa
      • 8.6.7.1. South Africa: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
    • 8.6.8. Cell Therapy Technologies Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.7. Cell Therapy Technologies Market - Latin America
    • 8.7.1. Latin America: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
    • 8.7.4. Cell Therapy Technologies Market - Mexico
      • 8.7.4.1. Mexico: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
    • 8.7.5. Cell Therapy Technologies Market - Brazil
      • 8.7.5.1. Brazil: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
    • 8.7.6. Cell Therapy Technologies Market - Argentina
      • 8.7.6.1. Argentina: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
    • 8.7.7. Cell Therapy Technologies Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Agilent Technologies Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Avantor, Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Becton, Dickinson and Company (BD)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Bio-Techne Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Corning Incorporated
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Danaher Corporation
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Fresenius SE & Co. KGaA
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Lonza Group AG
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Merck KGaA
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Sartorius AG
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Terumo Corporation
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Thermo Fisher Scientific Inc
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development